Saturday’s Daily Mail had a front page advert for a Danish pharmaceutical company, Novo Nordisk. It wasn’t an advert placed by the company, but the headline “Miracle of Daily Diet Jab” is probably better than an advert that money can buy. The story was about a ‘new’ diet drug, which was approved by the European Medicines Agency on 23rd January 2015. It’s not a new drug, but its approval for obesity is new. The drug is called liraglutide. It was approved by the European Medicine Agency (EMA) for type 2 diabetes in July 2009 and it was approved by the US Food and Drug Administration (FDA) for type 2 diabetes in January 2010. It is marketed as “Victoza” for type 2 diabetes. It was approved by the US FDA for obesity on 29th December 2014, where it is marketed as “Saxenda.”
The rest of this article is available to site members, who get access to all articles plus a weekly newsletter.
To continue reading, please login below or sign up for a membership. Thank you.